Effect of estrogen deficiency on cancellous and cortical bone structure and strength of the femoral neck in rats.
Eighty mature Sprague-Dawley rats were weight matched before ovariectomy (Ovx) or Sham surgery (Sham). Sham rats had free access to food and water throughout the experiment, whereas Ovx rats were kept on the pair-fed diet. Rats were euthanized at 4, 8, and 12 weeks after surgery, and had received fluorochrome bone markers at 9 and 2 days prior to euthanasia. In addition 10 rats were euthanized at the time of surgery serving as baseline controls. All rats were also scanned for body composition and bone mineral parameters by DEXA before surgery and euthanasia. Left proximal femurs (femoral necks) were used for bone histomorphometry, whereas right femurs were used for in vitro DEXA measurements and mechanical testing. Despite pair-feeding, ovariectomized rats had increased body weights and fat body mass, whereas the percent lean body mass steadily declined throughout the experiment. Mineral density of the whole femur and femoral neck was significantly higher in the Sham rats relative to Ovx animals. Ovariectomy reduced trabecular number and thickness, and increased trabecular separation and bone marrow space at the femoral midneck location. The structure of the remaining trabeculae was dramatically changed toward simpler struts as revealed by nodal analyses. Cortical thickness in Ovx rats was reduced because of the high endocortical resorption, which, in addition to cancellous bone resorption, resulted in fewer endocortico-trabecular connections. Femoral necks obtained from ovariectomized rats had reduced strength and were less stiff relative to controls. Because of the enormous clinical significance of the proximal femur for osteoporosis in humans, and the opportunity for studying bone BMD, mass, structure, and strength at the same skeletal location, the femoral neck appears superior to other skeletal sites routinely used for bone histomorphometry or mechanical testing in the Ovx rat model.
Bagi
C M
CM
Bayer Corporation, Institute of Bone and Joint Disorders, 400 Morgan Lane, West Haven, Connecticut 06516-4175, USA.
Ammann
P
P
Rizzoli
R
R
Miller
S C
SC
D015502:Absorptiometry, Photon; D000818:Animals; D001696:Biomechanical Phenomena; D001823:Body Composition / Q000502:physiology*; D001835:Body Weight / Q000502:physiology; D015519:Bone Density / Q000502:physiology*; D001862:Bone Resorption / Q000503:physiopathology; D004195:Disease Models, Animal; D004967:Estrogens / Q000172:deficiency*; D005260:Female; D005272:Femur Neck / Q000000981:diagnostic imaging / Q000473:pathology* / Q000503:physiopathology* / Q000648:ultrastructure; D005456:Fluorescent Dyes / Q000008:administration & dosage; D006801:Humans; D008855:Microscopy, Electron, Scanning; D015663:Osteoporosis, Postmenopausal / Q000503:physiopathology; D010052:Ovariectomy; D051381:Rats; D017207:Rats, Sprague-Dawley
D004967:Estrogens; D005456:Fluorescent Dyes